Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tonin, P.
Right arrow Articles by Narod, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tonin, P.
Right arrow Articles by Narod, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

OTHER

The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12–q21

Patricia Tonin, Olga Serova1, Jacques Simard2, Gilbert Lenoir1, Jean Feunteun3, Kenneth Morgan, Henry Lynch4 and Steven Narod*

Departments of Medicine and Human Genetics, Montreal General Hospital and McGill University 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada 1International Agency for Research on Cancer 150 Cours Albert Thomas, Lyon, France 2Medical Research Group in Molecular Endocrinology, CHUL Research Centre and Laval University St Foy, Quebec, Canada 3Institut Gustave Roussy Villejuif, France 4Creghton University School of Medicine, Department of Preventive Medicine and Public Health Omaha, NE, USA

*To whom correspondence should be addressed

Received June 23, 1994; Revised July 19, 1994; Accepted July 19, 1994

A gene for hereditary breast and ovarian cancer, BRCA1, has been mapped to chromosome 17q12–q21. This gene is responsible for cancer susceptibility in the majority of families with multiple cases of ovarian cancer and early-onset breast cancer. We report linkage results of a family with 10 cases of breast cancer and a single case of ovarian cancer. A recombinant event in this family places BRCA1 distal (telomeric) to the locus EDH17B2, which codes for the enzyme estradiol 17ß-dehydrogenase II. This recombinant is based on the appearance of breast cancer in a 45 year old woman. Under our genetic model, we estimate the probability that this woman carries a BRCA1 mutation to be 94%. These data further reduce the region of assignment of BRCA1 on chromosome 17q12–q21 and should expedite positional cloning of this important gene.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
C. R. Ferrone, D. A. Levine, L. H. Tang, P. J. Allen, W. Jarnagin, M. F. Brennan, K. Offit, and M. E. Robson
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
J. Clin. Oncol., January 20, 2009; 27(3): 433 - 438.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
E. M. Rakowicz-Szulczynska, B. Jackson, A. M. Szulczynska, and M. Smith
Human Immunodeficiency Virus Type 1-Like DNA Sequences and Immunoreactive Viral Particles with Unique Association with Breast Cancer
Clin. Vaccine Immunol., September 1, 1998; 5(5): 645 - 653.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.